Firms
Theme

NVST

Envista Holdings Corporation · NYSE

News

3 latest

Zacks Investment Research

Envista (NVST) is a Top-Ranked Value Stock: Should You Buy?

Envista (NVST), a dental platform company formed from Danaher's dental businesses, holds a #3 (Hold) Zacks Rank with a B VGM Score and A Value Style Score. The company features an attractive forward P/E ratio of 14.86 and has demonstrated a +19.4% average earnings surprise, making it a consideration for value-focused investors despite its hold rating.

Zacks Investment Research

Here's Why Envista (NVST) is a Strong Growth Stock

Zacks Premium offers investment research tools including Style Scores (Value, Growth, Momentum, and VGM) that complement the Zacks Rank system to help investors identify stocks with the best performance potential. The Zacks Rank has historically outperformed the S&P 500 with an average annual return of +23.86% since 1988. Envista (NVST) is highlighted as a stock to watch with a #3 Hold rank and B-rated Growth and VGM Style Scores, forecasting 28.6% year-over-year earnings growth.

Mentions NVST

The Motley Fool

Recently Appointed Cooper Companies Director Paul Keel Buys $250,000 Stock. Does This Signal Shares are a Buy?

Cooper Companies director Paul Keel purchased 4,701 shares worth $250,000 at $53.18 per share on September 11, 2026, following a 21% year-long stock decline. The insider buy is viewed as a bullish signal, suggesting confidence in the company's long-term growth prospects. Keel, who recently joined Cooper's board in May, brings extensive experience from his CEO role at Envista Holdings and prior positions at 3M.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $NVST · 0 threads

Sign in to post on $NVST

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev